Peter Attia· MD
you are using genetically heterogeneous mice these are not homogeneous so explain to folks why using these genetically heterogeneous mice is an important feature of the itps
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
you are using genetically heterogeneous mice these are not homogeneous so explain to folks why using these genetically heterogeneous mice is an important feature of the itps
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
what we wanted to do in developing a genetically heterogeneous stock was avoid that we did not want to trick ourselves into picking a drug that only worked on black six mice and conversely we did not want to miss a really good drug that just happened not to work on black six mice